Invacare Corp. (IVC) Trading Down 1.7%
Invacare Corp. (NYSE:IVC) traded down 1.7% on Wednesday . The company traded as low as $11.45 and last traded at $11.60, with a volume of 184,050 shares traded. The stock had previously closed at $11.80.
Separately, Zacks Investment Research upgraded Invacare Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, July 26th.
The stock’s market cap is $372.26 million. The firm has a 50 day moving average price of $12.29 and a 200 day moving average price of $12.67.
Invacare Corp. (NYSE:IVC) last announced its quarterly earnings data on Thursday, July 28th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.09. During the same period last year, the business posted ($0.23) earnings per share. The business earned $275 million during the quarter, compared to analyst estimates of $270.10 million. The company’s revenue for the quarter was down 3.9% compared to the same quarter last year. Equities research analysts forecast that Invacare Corp. will post ($0.95) earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 13th. Shareholders of record on Tuesday, July 5th were issued a dividend of $0.0125 per share. This represents a $0.05 annualized dividend and a yield of 0.43%. The ex-dividend date of this dividend was Thursday, June 30th.
In related news, Director Clifford D. Nastas bought 5,000 shares of the company’s stock in a transaction on Friday, May 6th. The shares were purchased at an average price of $11.01 per share, for a total transaction of $55,050.00. Following the completion of the transaction, the director now directly owns 14,932 shares in the company, valued at approximately $164,401.32. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Dean J. Childers bought 10,000 shares of the company’s stock in a transaction on Monday, May 16th. The shares were bought at an average price of $10.40 per share, for a total transaction of $104,000.00. Following the transaction, the senior vice president now owns 35,672 shares of the company’s stock, valued at $370,988.80. The disclosure for this purchase can be found here.
Several large investors recently bought and sold shares of the company. Nationwide Fund Advisors increased its stake in Invacare Corp. by 195.2% in the fourth quarter. Nationwide Fund Advisors now owns 94,166 shares of the company’s stock valued at $1,638,000 after buying an additional 62,271 shares in the last quarter. BlackRock Advisors LLC increased its stake in Invacare Corp. by 3.7% in the fourth quarter. BlackRock Advisors LLC now owns 1,244,925 shares of the company’s stock valued at $21,649,000 after buying an additional 44,925 shares in the last quarter. Brandes Investment Partners LP increased its stake in Invacare Corp. by 27.2% in the fourth quarter. Brandes Investment Partners LP now owns 72,728 shares of the company’s stock valued at $1,264,000 after buying an additional 15,550 shares in the last quarter. Finally, California State Teachers Retirement System increased its stake in Invacare Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 59,998 shares of the company’s stock valued at $1,043,000 after buying an additional 1,084 shares in the last quarter.
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.